Adult mesenchymal stem cells and the NO pathways

Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH 44106.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 02/2013; 110(8). DOI: 10.1073/pnas.1221406110
Source: PubMed
7 Reads
  • Source
    • "In addition, these MSCs differentiate in hepatocyte-like cells and secrete a variety of cytokines and growth factors that have both paracrine and autocrine activities. These secreted bioactive factors suppress the local immune system, inhibit fibrosis (scar formation) and apoptosis, enhance angiogenesis, and stimulate mitosis and differentiation of tissue-intrinsic reparative cells and stem cells [33]. MSCs are promising candidates for the repair of tissues altered by radiation exposure, as described for skin regeneration [8, 9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the potential therapeutic effect of the infusion of hMSCs for the correction of liver injuries, we performed total body radiation exposure of NOD/SCID mice. After irradiation, mir-27b level decreases in liver, increasing the directional migration of hMSCs by upregulating SDF1 α . A significant increase in plasmatic transaminases levels, apoptosis process in the liver vascular system, and in oxidative stress were observed. hMSC injection induced a decrease in transaminases levels and oxidative stress, a disappearance of apoptotic cells, and an increase in Nrf2, SOD gene expression, which might reduce ROS production in the injured liver. Engrafted hMSCs expressed cytokeratin CK18 and CK19 and AFP genes indicating possible hepatocyte differentiation. The presence of hMSCs expressing VEGF and Ang-1 in the perivascular region, associated with an increased expression of VEGFr1, r2 in the liver, can confer a role of secreting cells to hMSCs in order to maintain the endothelial function. To explain the benefits to the liver of hMSC engraftment, we find that hMSCs secreted NGF, HGF, and anti-inflammatory molecules IL-10, IL1-RA contributing to prevention of apoptosis, increasing cell proliferation in the liver which might correct liver dysfunction. MSCs are potent candidates to repair and protect healthy tissues against radiation damages.
    11/2013; 2013(4):151679. DOI:10.1155/2013/151679
  • [Show abstract] [Hide abstract]
    ABSTRACT: Endodontic management of immature permanent teeth with necrotic pulps is both a clinical problem for dental practitioners and a public health care problem. Although it is feasible to perform apexification procedures, the long‐term survival of these teeth is questionable due to thin, incompletely formed dentinal walls. Regenerative endodontic procedures have emerged as a viable treatment alternative for these teeth. This review summarizes the evolution of these procedures while presenting recent advances, including treatment protocol modifications based on translational studies and future bioengineering approaches.
    Endodontic Topics 03/2013; 28(1). DOI:10.1111/etp.12040
  • [Show abstract] [Hide abstract]
    ABSTRACT: Regenerative medicine is a rapidly evolving multidisciplinary, translational research enterprise whose explicit purpose is to advance technologies for the repair and replacement of damaged cells, tissues, and organs. Scientific progress in the field has been steady and expectations for its robust clinical application continue to rise. The major thesis of this review is that the pharmacological sciences will contribute critically to the accelerated translational progress and clinical utility of regenerative medicine technologies. In 2007, we coined the phrase "regenerative pharmacology" to describe the enormous possibilities that could occur at the interface between pharmacology, regenerative medicine, and tissue engineering. The operational definition of regenerative pharmacology is "the application of pharmacological sciences to accelerate, optimize, and characterize (either in vitro or in vivo) the development, maturation, and function of bioengineered and regenerating tissues." As such, regenerative pharmacology seeks to cure disease through restoration of tissue/organ function. This strategy is distinct from standard pharmacotherapy, which is often limited to the amelioration of symptoms. Our goal here is to get pharmacologists more involved in this field of research by exposing them to the tools, opportunities, challenges, and interdisciplinary expertise that will be required to ensure awareness and galvanize involvement. To this end, we illustrate ways in which the pharmacological sciences can drive future innovations in regenerative medicine and tissue engineering and thus help to revolutionize the discovery of curative therapeutics. Hopefully, the broad foundational knowledge provided herein will spark sustained conversations among experts in diverse fields of scientific research to the benefit of all.
    Pharmacological reviews 04/2013; 65(3):1091-1133. DOI:10.1124/pr.112.007393 · 17.10 Impact Factor
Show more


7 Reads
Available from